CytoSorbents Is At The Forefront Of Blood Purification. Targets $20 Billion Opportunity In Critical Care.
Feb 21
Based on its unique porous polymer bead technology, CytoSorb is proven and effective at treating deadly inflammation due to illnesses (flu, sepsis, burns, etc.) and cardiac surgery. This plug and play $1,000 blood filter (80% gross margins) is compatible with a hospital’s existing medical equipment, plus home care equipment. Use cases for CytoSorbents’ proprietary...
Read More